CDMO Stocks and Leader (Korea)
The CDMO theme has 6 member stock(s) today, with an average return of -0.8%. The leading stock is 삼성바이오로직스 (+5.1%, trading value 124,768,781,500).
CDMO (Contract Development and Manufacturing Organization) refers to services providing drug development and contract manufacturing for pharmaceutical and biotech companies, with service areas varying from antibody therapeutics and cell/gene therapies to oligonucleotides. Stocks in this theme differ substantially in scale and contract structure, ranging from large-scale contract manufacturers to small-to-medium firms focused on specific modalities.
Because the timing of contract announcements often differs from actual revenue recognition, it is advisable on volatile trading days to verify whether movements are driven by new order disclosures or broader sector trends. The leading stock on this page is based on daily price performance and does not guarantee order backlog or financial results. Comparing overlapping stocks in the Biosimilar and Bio themes helps clarify where market attention is centered.
| Stock | Price | Return | Trading Value |
|---|---|---|---|
| 삼성바이오로직스 | 1,436,000 | +5.1% | 124,768,781,500 |
| 바이넥스 | 6,020 | -1.0% | 402,391,110 |
| 차바이오텍 | 6,690 | -1.0% | 929,151,000 |
| 폴라리스AI파마 | 5,510 | -1.2% | 79,938,070 |
| 에스티팜 | 72,200 | -2.4% | 8,009,053,900 |
| 프레스티지바이오로직스 | 1,143 | -4.2% | 217,320,602 |
This page's data is for reference only and is not investment advice. Actual market data may differ.